Smith, Toby ORCID: https://orcid.org/0000-0003-1673-2954, Maidment, Ian, Hebding, Jennifer, Madzima, Tairo, Cheater, Francine, Cross, Jane ORCID: https://orcid.org/0000-0002-7003-1916, Poland, Fiona ORCID: https://orcid.org/0000-0003-0003-6911, White, Jacqueline, Young, John and Fox, Chris ORCID: https://orcid.org/0000-0001-9480-5704 (2014) Systematic review investigating the reporting of comorbidities and medication in randomized controlled trials of people with dementia. Age and Ageing, 43 (6). pp. 868-872. ISSN 0002-0729
Full text not available from this repository. (Request a copy)Abstract
Dementia is a debilitating condition characterised by global loss of cognitive and intellectual functioning, which reduces social and occupational performance. This population frequently presents with medical co-morbidities such as hypertension, cardiovascular disease and diabetes. The CONSORT statement outlines recommended guidance on reporting of participant characteristics in clinical trials. It is, however, unclear how much these are adhered to in trials assessing people with dementia. This paper assesses the reporting of medical co-morbidities and prescribed medications for people with dementia within randomised controlled trial (RCT) reports.
Actions (login required)
View Item |